amino acids. A number of residues within this domain are highly conserved between both types of protein kinase, but the protein-tyrosine kinases and protein-serine/threonine kinases are distinguished by specific signature motifs (3).
A priori, however, it was not clear whether these motifs were important in determining amino acid specificity or whether they might reflect the nature of the first protein PKA, but the backbone of the substrate peptide had to be positioned differently at the active site in order to accommodate the tyrosine and prevent its hydroxyl from protruding into the ATP-binding
site. it with that of the C-subunit of PKA (Fig. 1) Al- though there are some differences in the small lobe and in the orientation of the two lobes relative to one another, the major differences in the two enzymes, emphasized in the superimposed structures in Fig. 2 , are in the activation loop in the large lobe near the cleft interface. Clearly, the conformation of this ioop in most protein kinases depends critically on the phosphorylation state of the protein. To emphasize the specific features that differ in the two enzymes, the two lobes will be discussed separately. The residues of particular importance in PKA and IRK, along with their nomenclature, are indicated in Table  1 .
THE NH2-TERMINAL ATP-BINDING LOBE
The NH2-terminal ATP-binding lobe constitutes an ATPbinding motif that is unique to the protein kinase family. The ATP-binding lobes of IRK and PKA are shown with conserved features of the sequence highlighted in Fig. 3 . In IRK, this lobe is actually in a more open conformation relative to the large lobe, in part due to the position of the activation loop, but in Fig. 3 they are superimposed. The 5-stranded 13-sheet is highly conserved, in particular, the glycine-rich loop between 131 and f32 and the invariant lysine in 133, whereas the helical regions differ in several regards. The small B-helix is so far unique to PKA. The C-helix, in contrast, which contains a conserved glutamate (Glu9' in PKA and Glut0'17 in IRK) that is part of the ATP-binding site, is present but is displaced in IRK relative to the 13-sheet (Fig. 3) , and is also somewhat shorter. Consequently, this structural motif is located relatively far from the active site cleft in the overall structure.
In the active conformation, this helix must move into place so that G1u1047 can come into close proximity to Lys'#{176}3#{176} and the catalytic loop between 136 and 137 in the large lobe. In the ternary complex of PKA with MgATP and PKI (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) , Glu91
positions Lys72 for binding to the a-and 13-phosphates of ATP, but also is itself less than 4 Afrom the catalytic base,
Asp', at the site of phosphotransfer.
Of the 11 conserved residues highlighted in Fig. 1 , Glu'#{176}47 is the only one that is displaced significantly relative to PKA in any of the protein kinase structures solved so far. In Cdk2, this helix is displaced even further and twisted so that the conserved glutamate is actually fully exposed to solvent. Cyclin is thought to bind to and alter the conformation of this region of Cdk2 generating an active conformation (10, 23) (see "Note added in proof"); in the insulin receptor, the plasma membrane or the other molecule in the dimer may influence the conformation of this region upon insulin binding.
THE ACTIVATION LOOP
The most significant differences between IRK and PKA are found in the activation loop in the large lobe, a segment that displays considerable conformational diversity depending on the phosphorylation state of the enzyme. Probably the most unexpected feature of the IRK structure is the position of this unphosphorylated loop and the apparent stability of this inactive conformation.
This segment, shown in Fig. ' IA, is bridged by two conserved residues whose positions remain more or less fixed. In PKA, Asp at the end of 138 binds to the activating Mg2 ion in the C-subunit that bridges the 13-and 'y-phosphates of ATP (Fig. 4C) . At the other end of this segment is G1u208, which is fixed by its interaction with Arg#{176}. This buried ion pair, conserved so far in nearly all of the protein kinase structures, is also present in IRK. lion of most of the P+ 1 loop, is ordered very differently in IRK (Fig. 4B) . Furthermore, unlike the structure of unphosphorylated Cdk2 where this region is also ordered very differently from PKA, thissegment in IRK is well-defined, indicating that the inactive conformation of this region may be quite stable.
Two featuresof the IRK structureare particularly remarkable.
First is the conserved DFG motif where Phe"5' folds over into the ATP-binding site. By filling the adenine pocket, this side chain precludes ATP binding (Fig. 'IA) . After this is a very stable region that contains the three tyrosinephosphorylationsites.The polypeptide chain is positionedso thatone of the tyrosines, Tyr1162, isoriented with its hydroxyl group lying in approximately the same position as the P-site serine hydroxyl in a substrate complex of PKA. The following residue, Tyr'163, lies in the somewhat distorted P+ 1 binding site. As discussed later, Pro72 is responsible for positioning the P-site tyrosine in the phosphotransfer site, whereas in PKA the P-site serine is positioned by interactions with the peptide backbone. (14) , these regions, shown in Fig. 4 and Fig. 5 (subdomains VIB and VIII) (24),converge at the siteof catalysis and interact with one another as well as with the substrate. Protein-serine/threonine kinases have a lysine in the conserved catalytic loop whereas protein-tyrosine kinases have RAA (cytoplasmic protein-tyrosine kinases) or AAR (receptor protein-tyrosine kinases).In PKA (Fig.5B) , Lys', interacts with Thr 201 in the P+ 1 loop and also binds to the P-2 backbone carbonyl in the substrate, thus helping to orient the peptide for phosphotransfer. Lys'68 also binds to the y-phosphate of ATP (7). In the IRK, (Fig. 5A) , Arg"36 in AAR interacts with Asp"61 and Tyr"62 in the activation loop, Asp'132, the catalytic base, and Trp"75 in the P+1 loop. The Arg"36 guanidinium group is bent away from the y-phosphate binding site. It also comes close to the aromatic ring of the P-site tyrosine. Because there is still no PKA structure available that does not contain peptide, it cannot be ascertained whether Lys' also folds away from the y-phosphate binding site when peptide is missing. This lysine in PKA is known to be protected from modification with acetic anhydride both in the free enzyme and in the ternary complex (26 B) The activation loops in A and C are superimposed.
G The hydrogen bonding in the PKA activation loop. Also shown in p-strand 6,ATP (red) and a portion of the inhibitor peptide (R"3RNAlt"). in the largelobe,alsocontributeto docking of the tyrosine ring cannot be determined from this inactive conformation.
Recognition of amino acid side chains of the residues in the substrate that flank the P-site must also be conserved. For example, in PKA one of the residues in the P+ 1 loop, Glu203, also helps to recognize the P-6 Arg in the inhibitor peptide (Fig. 6B) . In IRK this residue is replaced with Arg1174 ( Fig. 6A) , which is consistent with IRK's preference for acidic side chains (28). In PKA, Tyr204 also In this regard, the most striking feature of the insulin receptor catalytic domain structure is that Tyr''62, to the more open conformation. The authors propose that Tyr"62 is, in fact, phosphorylated first in trans by the neighboring catalytic domain in the insulin receptor dimer, and that this could be triggered by an insulin-induced conformational change that allows ATP binding to occur. This model is consistent with the general requirement for transphosphorylation in the activation of receptor protein-tyrosine kinases, but is hard to imagine topologically, especially without knowing how the two protomers in the dimer, both of which are anchored to the membrane, interact with one another. Once phosphorylated, Tyr"62 would no longer be bound in the active site and presumably would bind somewhere else, thus stabilizing an active conformation.
The other two tyrosines in the activation loop would then, in principle, be accessible for phosphorylation.
At exactly what stage an exogenous substrate or the autophosphorylation sites in the juxtamembrane domain and the COOH-terminal tail would have access to the active site is unclear.
SPECIFICITY OF INSULIN

RECEPTOR-SUBSTRATE INTERACTIONS
Although the mechanism of autoactivation of the insulin receptor is still not resolved, the structure does allow us to make some predictions about the primary sequence specificity of the insulin receptor. Four glutamates (Glu'70, G1u127, G1u203, and Glu230) in PKA interactwith the P-2 and P-3 basic amino acids in PKA substrates. The equivalent residues in the insulin receptor catalytic domain are Arg"36, Asp'#{176}83, Arg"74, and G1u1201. Additional residues that are potential candidates for interaction with the P-2 and P-3 residues in the substrate are Arg'089, Lys'085, and Lysl#{174}2. This configuration of basic residues provides an explanation for IRK having a preference for phosphorylating tyrosines with acidic residues upstream.
Indeed, several of the tyrosines known to be phosphorylated in the preferred insulin receptor protein-tyrosine kinase substrate IRS-1 are in this sequence context (36), and an analysis of the preferred sequences phosphorylated in a degenerate peptide library confirms the preference for glutamates upstream of the tyrosine (28). The IRK also displays a preference for methionine or phenylalanine at the P+1 position in peptide substrates. In one sense the activation loop in the inactive conformation acts as a surrogate peptide substrate with Tyr11 replacing the P+ 1 hydrophobic residue. This can best be seen in a space filling model of the P+ 1 loop where the P-site serine (designated as Ala377 in PKI) and P+1
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isoleucine fill the region in PKA (Fig. 6A) , and Tyr"62 and Tyr"' fill the corresponding region in IRK (Fig. 6B) methionine by threonine in the RET receptor protein-tyrosine kinase is the cause of multiple endocrine neoplasia (MEN) type 2B (37), and it has been speculated that this may be a result of an altered RET substrate specificity through a change in P+1 selectivity (28).
UNRESOLVED QUESTIONS
The structure of the unactivated insulin receptor catalytic domain provides many insights, but leaves a number of questions.
Most of these concern how insulin binding to the intact receptor dimer increases catalytic activity. Because activation of the intact full-length receptor is triggered by insulin binding to the extracellular domain, it may not be possible to establish the precise mechanism that triggers the activation of the actual receptor from this truncated form of IRK. The plasma membrane, the juxtamembrane domain, and/or the COOH-terminal tail, as well as the presence of ATP, could all change the conformation of catalytic center, particularly the orientation of the two lobes relative to one another. The two noncatalytic domains as well as the membrane will also almost certainly affect how the nonconserved segments at both ends of the catalytic domain interact with the catalytic core. To understand the mechanism of activation at the molecular level we need to know the orientation of the two catalytic domains in the dimer and how they interact, what insulin-induced conformational change triggers transphosphorylation, how phosphorylation of the activation loop is achieved in trans, and what conformation it adopts after phosphorylation.
One unanswered question is whether ATP can even bind to this inactive form of the IRK and whether this form will exist in the cell where ATP concentrations are millimolar. Because ATP binding to the soluble IRK will automatically lead to activation, a structure of IRK bound to a nonhydrolyzable analog of ATP may be needed to answer this question. Another question unanswered by the IRK structure is the position of the COOH-terminal tail, which contains two sites of autophosphorylation, because the tail is deleted in the crystallized protein.
It will be important to determine whether the COOH-terniinal tail binds to the active site and serves as an autoinhibitor as the COOH-terminal tail of twitchin appears to do. The fact that the insulin receptor COOH-terminal tail can be removed by proteolysis without activating the kinase might suggest that it does not occupy the active site (38). Insulin is proposed to induce a conformational change in the receptor dimer, thus allowing Tyr"62 in one subunit to be phosphorylated in trans by the other subunit,which perforcemust alsobe in the ATP-bound state. This model fits with the observation that Tyr"62 is one of the first sites to be phosphorylated after insulin binding. However, an alternative model, consistent with Tyr"58 being one of the first tyrosines to be phosphorylated and itbeing more accessiblethan Tyr1t62 in the inactive IRK, is that Tyr11 is in fact phosphorylated first in trans. Once phosphorylated, P.Tyr" could bind into a pocket created by Arg31 and Arg"53, which would result in a further conformational change of the activation loop exposing Tyr"62 and allowing it to be phosphorylated. Once phosphorylated, P.Tyr62 could bind to another site or displace P.Tyr"", stabilizing the active conformation. In principle, one ought to be able to distinguish between these models based on the properties of insulin receptor mutants in which single activation loop tyrosines have been mutated to phenylalanine.
Unfortunately, the autophosphorylation site mutagenesis studies are not completely in agreement as to the roles of the individual tyrosines (29-35).
None of the tyrosines is absolutely essential for insulin receptor activation.
In at least some studies, the Tyr""Phe mutation by itself has a significant inhibitory effect on activation (31, 35), suggesting that it could play an important role. However, it is clear that the Tyr' '62Phe mutation alone has a dramatic effect, and ultiinatelyphosphorylationof Tyr"62 must be requiredforthe insulin receptor to achieve an activated state. The Tyr' UPhe mutation has the least effect, but the phosphorylation of Tyr' ' appears to be required to attain maximal activation.
Ultimately, it may turn out that phosphorylation of any of the tyrosines in the IRK activation loop is capable of triggering the conformation change that allows additional tyrosines to be phosphorylated.
If phosphorylation of accessible activation loop tyrosines can trigger this conformational change, then it is possible that phosphorylation of activation loop tyrosines in trans by another protein-tyrosine kinase could trigger insulin-independent activation. It is known that Src can phosphoi-ylate activation loop tyrosines in the insulin receptor in vitro, leading to its activation (39).
What does the IRK structure tell us about other receptor protein-tyrosine kinases and protein-tyrosine kinases in general? The members of the insulin receptor protein-tyrosine kinase subfamily are unique in that they exist as disulfide-bonded dimers, and therefore ligand binding can in principle simply elicit an activating conformational change rather than causing dimerization.
For this reason, the inactive conformation of the insulin receptor may be designed to preclude accidental transphosphorylation. The insertion of Tyr"62 into the active site and the apparent inability of this conformation to bind ATP would be an efficient way to achieve this. Indeed, if the stability of the dephosphorylated activation loop is maintained in the cell, it may mean that the unphosphorylated enzyme is more stablethan the activephosphorylated enzyme. This could be a mechanism to ensure that the insulin receptor rapidly returns to the inactive state once it is dephosphorylated. However, for most other receptor protein-tyrosine kinases, which are activated by ligand-induced dimerization, it is not clear that this fail-safe mechanism is necessary. Indeed, the activation loops of about half the known receptor protein-tyrosine kinase subfamilies have only a single tyrosine, which appears to be equivalent to Tyr". For this type of receptor protein-tyrosine kinase, phosphorylation of the activation loop tyrosine in trans, followed by its binding to a surface pocket, might be sufficient to activate the catalytic domain. The fact that insulin receptor kinase activity becomes ligand-independent after autophosphorylation (40), whereas this is not the case for other studied receptor protein-tyrosine kinases, also suggests that the activation mechanism of the insulin receptor may be specialized.
Nevertheless, it will be interesting to learn whether other protein-tyrosine kinases are cis-inhibited by insertion of an activation loop autophosphorylation site tyrosine into the activesite, and whether activation occurs by phosphorylation in trans within a dimer. There are now several examples of protein-serine kinases that are activated by transphosphorylation of one or more residues in the activation loop by a separate protein kinase. One recent example is protein kinase C, where phosphorylation of the activation loop threonine equivalent to Thr'97 in PKA is first phosphorylated in trans by another protein kinase, thus activating subsequent autophosphorylation (41). Transphosphorylation, followed by true autophosphorylation, may be a common activation mechanism for protein-serine kinases and could also be a mechanism for activation of protein-tyrosine kinases as well. Another question is how tyrosines lying outside the catalytic domain are autophosphorylated?
The COOH-terminal tail of the insulin receptor, which contains two other autophosphorylation sites, is located on the face opposite the catalytic cleft. Although it could be phosphorylated in cis if it were to fold around the catalytic domain, it is plausible that itcould be phosphorylated in trans. Likewise the sites in the juxtamembrane domain would be most easily phosphorylated in trans. The kinase insert in the PDGF receptor family, which contains several autophosphorylation sites, is also on the opposite face to the catalytic cleft, and in this case it can be phosphorylated only in trans. Structures of the complete cytoplasmic domain of the insulin receptor dimer with peptide substrate and ATP bound will be eagerly awaited so that a full understanding of the mechanisms of activation and autophosphorylation of the insulin receptor protein-tyrosine kinase and its interaction with substrates can be attained.
Note added in proof:
The crystal structure of a cyclin AICdk2 
